January 10th 2021, 3:00pm
The FDA has lifted a partial clinical hold on a phase 2 trial evaluating a novel therapy in patients with acute myeloid leukemia following an allogenic stem cell transplant.
December 31st 2020, 2:00pm
Here is a list of some recent trials that launched within the cancer space in December.
December 29th 2020, 2:00pm
Here are the top 10 FDA oncology drug approvals that you may have missed this year.
December 26th 2020, 3:00pm
A roundup of some of the most read news and updates in acute myeloid leukemia in 2020 from CURE®.
December 24th 2020, 4:00pm
In this episode of the “CURE Talks Cancer” podcast, Dr. Dan Pollyea discusses the basics of AML, as well as treatment options currently available for patients.
December 18th 2020, 1:00am
Watch our Acute Myeloid Leukemia Webinar where an expert panel discussed topics highly relevant to patients, caregivers and advocates right now.
November 26th 2020, 2:00pm
Here is a list of some recent trials that launched within the cancer space in November.
October 16th 2020, 6:20pm
After granting accelerated approval in 2018, the Food and Drug Administration approved Venclexta in combination with Vidaza, Dacogen or low dose cytarabine in newly diagnosed patients with AML.
September 10th 2020, 1:00pm
Adding Venclexta to Vidaza chemotherapy improved survival and boosted the complete remission rate in previously untreated patients with AML who had coexisting health conditions and/or were age 75 or older, results from a phase 3 clinical trial showed.
September 1st 2020, 5:45pm
The approval for patients with acute myeloid leukemia was based on data from the phase 3 QUAZAR AML-001 trial, which demonstrated that patients who received Onureg achieved a median overall survival of 24.7 months compared to 14.8 months for those who received placebo.
5 Recent COVID-19 News and Updates That Patients With Cancer May Have Missed
FDA Approves Cabometyx-Opdivo For Metastatic RCC Treatment
Novel Therapy Granted Priority Review By FDA for Treatment of Anal Cancer Subset
COVID-19 'Retired' Me, But Now I Can Reach For My Life Goals
